Payment & Shipping Terms:
|Categories:||Sex Steroid Hormones, API; Chemical Raw Medicine; Pharmaceutical Raw Materials||CAS No.:||147359-76-0, 167933-07-5|
|Molecular Formula:||C20H21F3N4O||Molecular Weight:||390.40|
Flibanserin Estradiol Steroid Hormone 167933-07-5 For Pre - Menopausal Women
Flibanserin, a Medical Treatment for Female Hypoactive Sexual Desire Disorder
Flibanserin ( Addyi) is a new drug being investigated for the prevention of HSDD in woman. HSDD, is a relatively new term developed to describe Hypoactive Sexual Desire Disorder which basically means a woman whose is otherwise healthy has a lacking libido, or a lack of sexual desire. Studies show that about 10-20% of women face this problem and some say HSDD outnumbers men with sexual problems. Flibanserin is classified as a 5-HT serotonin receptor agonist and a dopamine D4 receptor partial agonist. It is a Non-Hormonal agent that in essence increases dopamine and noradrenalin while reducing Serotonin in the brain. This in return seemingly has a positive effect on a woman's sexual craving who was otherwise lacking in this area. The benefits of it being Non-Hormonal are that it will not have the problems associated with other hormonal treatments such as a negative altered mood among other issues.
Flibanserin, (or rumored trademark name Girosa or Ectris) created by Boehringer Ingelheim, a German Pharmaceutical company, was originally being created as an anti-depressant but after testing for such was found to be a poor treatment for depression. Similarly how Viagra was being experimented with originally to treat high blood pressure and angina (a heart condition). Interestingly while females where being questioned about their trial experiences for depression, a large number noticed an unexpected positive side effect from Flibanserin. They discovered that many woman where reporting more sexual interest and overall satisfying sexual experiences than before. Apparently some woman who where taking part in the trials didn't want to stop the testing based on this fact alone. This led the company to clinically testing this new compound for this exact reason.
Flibanserin Functions & Traits
Certificate Of Analysis
|Test standard||In-house quality standard||Expiry date||2017-06-04|
|Loss on Drying||≤1.0%||0.5%|
|Conclusion:The product meets In-house specifications.|
We are ready to serve you ,please contact without any doubt: